1) PMOP(primary Type I osteoporosis)
原发I型骨质疏松
1.
OBJECTIVE:To study the technical conditions and parameters of DiaionHP-20 macroporous adsorption resin for the purification of the anti-PMOP(primary Type I osteoporosis) active fraction from Camellia semiserrata seed.
目的:研究大孔吸附树脂DiaionHP-20富集纯化南山茶种子抗原发I型骨质疏松有效部位的工艺条件。
2) type I primary osteoporosis
I型原发性骨质疏松症
3) I type osteoporosis
I型骨质疏松
1.
[Objective] To explore the characteristics and influencing factors of the surface electromyogram(SEMG)of I type osteoporosis patients.
[方法]运用多元回归方法和决策树模型等方法分析I型骨质疏松患者肌电信号的影响因素。
4) Osteoporosis
[英][,ɔstiəʊpə'rəʊsɪs] [美]['ɑstɪopə'rosɪs]
原发性骨质疏松
1.
2)years,10 years as an age stage),159 patients with osteoporosis and 93 type 2 diabetic patients were systematically determined.
方法采用ELISA法分析97例不同年龄正常人，159例原发性骨质疏松症患者及93例糖尿病患者尿Crosslaps和血清BGP水平变化。
5) primary osteoporosis
原发性骨质疏松
1.
A bone- fortifying compound for treating primary osteoporosis and its antioxidant action;
壮骨合剂治疗原发性骨质疏松及其抗氧化作用初探
2.
Primary osteoporosis sickness pathogenesis and prevention theory discussion
原发性骨质疏松症的病机及防治理论探讨
3.
To study the mechanism of “Gengnianchun Liquid” in the prevention of experimental primary osteoporosis, SD female rats were oophorotomized to make osteoporosis.
为探讨更年春方(GNC)预防实验性原发性骨质疏松的作用机理,采用10~12月龄SD雌性大鼠去卵巢建立骨质疏松模型,用GNC灌药4个月,RT PCR法检测胫骨骨骺ERα、ERβ、OPG、RANKL、osf2 /cbfal与TRAPmRNA的表达。
6) Primary Osteoporosis
原发性骨质疏松症
1.
The Clinical Research of MiGu Capsule s Therapeutic Effectiveness on Primary Osteoporosis;
密骨胶囊治疗原发性骨质疏松症(肝肾不足证)的临床研究
2.
Clinical value of bone metabolic markers in diagnosis and treatment of primary osteoporosis;
骨代谢指标在原发性骨质疏松症诊治中的临床价值
3.
Clinical study of Gu-Jian capsule in treating primary osteoporosis with kidney-yang deficiency syndrom;
骨健胶囊治疗原发性骨质疏松症的临床研究
补充资料：骨质疏松症
| 骨质疏松症 osteoporosis 由于各种原因引起的骨代谢障碍。主要表现为单位体积内骨量降低，骨基质有机成分及钙盐沉着均减少，但基本结构保持不变。临床表现主要为骨痛和骨折，以脊椎骨折、股骨颈骨折及桡骨远端骨折多见。X射线表现以骨皮质变薄及骨小梁减少为特征。骨密度测定常用光子吸收测量。防治的重点在于预防骨折的发生，老年要补充钙和性激素，降钙素可同时预防和治疗骨质疏松症。 |
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条